Where Will Hershey Stock Be In 1 Year?
Chocolate stocks used to be the epitome of sleepy stability,…
Sell
36
KMB Quote, Financials, Valuation and Earnings
Last price:
$132.28
Seasonality move
:
-0.03%
Day range:
$130.91 - $132.48
52-week range:
$124.10 - $150.45
Dividend yield:
3.75%
P/E ratio:
18.03x
P/S ratio:
2.25x
P/B ratio:
39.89x
Volume:
2.1M
Avg. volume:
2.4M
1-year change:
-4.08%
Market cap:
$43.9B
Revenue:
$20.1B
EPS (TTM):
$7.34
Analysts' Opinion
-
Consensus RatingKimberly-Clark has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 12 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $142.40, Kimberly-Clark has an estimated upside of 7.59% from its current price of $132.36.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $118.00 representing 100% downside risk from its current price of $132.36.
Fair Value
-
According to the consensus of 16 analysts, Kimberly-Clark has 7.59% upside to fair value with a price target of $142.40 per share.
KMB vs. S&P 500
-
Over the past 5 trading days, Kimberly-Clark has overperformed the S&P 500 by 2.38% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Kimberly-Clark does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Kimberly-Clark revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Kimberly-Clark reported revenues of $4.8B.
Earnings Growth
-
Kimberly-Clark earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Kimberly-Clark reported earnings per share of $1.70.
Enterprise value:
50.7B
EV / Invested capital:
--
Price / LTM sales:
2.25x
EV / EBIT:
16.33x
EV / Revenue:
2.57x
PEG ratio (5yr expected):
0.52x
EV / Free cash flow:
21.21x
Price / Operating cash flow:
18.58x
Enterprise value / EBITDA:
12.94x
Gross Profit (TTM):
$7B
Return On Assets:
14.61%
Net Income Margin (TTM):
12.48%
Return On Equity:
201.79%
Return On Invested Capital:
27.9%
Operating Margin:
15.89%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $20.3B | $20.4B | $19.7B | $5.1B | $4.8B | |
| Gross Profit | $6.4B | $7.2B | $7B | $1.9B | $1.7B | |
| Operating Income | $2.8B | $3.1B | $3.2B | $853M | $769M | |
| EBITDA | $3.5B | $3.1B | $3.9B | $1B | $976M | |
| Diluted EPS | $5.84 | $5.44 | $7.34 | $1.91 | $1.70 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5.1B | $5.9B | $5.9B | $5.6B | $5.3B | |
| Total Assets | $17.2B | $18.7B | $18.2B | $17.1B | $16.3B | |
| Current Liabilities | $6.7B | $7.3B | $7.1B | $6.9B | $6.9B | |
| Total Liabilities | $16.5B | $17.8B | $17.3B | $15.9B | $15.1B | |
| Total Equity | $746M | $854M | $861M | $1.2B | $1.2B | |
| Total Debt | $8.8B | $9.1B | $8.5B | $8B | $7.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $3.1B | $3.4B | $3.1B | $438M | $327M | |
| Cash From Investing | -$784M | -$484M | -$38M | -$181M | -$119M | |
| Cash From Financing | -$2.3B | -$2.5B | -$3.4B | -$485M | -$683M | |
| Free Cash Flow | $2.3B | $2.6B | $2.4B | $244M | $123M | |
KMB
Sector
Market Cap
$43.9B
$260.3M
Price % of 52-Week High
87.98%
75.4%
Dividend Yield
3.75%
0%
Shareholder Yield
5.91%
2.89%
1-Year Price Total Return
-4.08%
-8.88%
Beta (5-Year)
0.349
0.382
Dividend yield:
3.75%
Annualized payout:
$4.88
Payout ratio:
66.33%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$129.48
200-day SMA
Sell
Level
$135.91
Bollinger Bands (100)
Sell
Level
131.89 - 141.75
Chaikin Money Flow
Buy
Level
503.3M
20-day SMA
Buy
Level
$131.11
Relative Strength Index (RSI14)
Buy
Level
50.02
ADX Line
Sell
Level
27.62
Williams %R
Neutral
Level
-21.2987
50-day SMA
Sell
Level
$134.29
MACD (12, 26)
Sell
Level
-1.81
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Neutral
Level
111.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.2052)
Sell
CA Score
(Annual)
Level (-1.2074)
Buy
Beneish M-Score
(Annual)
Level (-2.8031)
Buy
Momentum Score
Level (5)
Sell
Ohlson Score
Level (1.4473)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Stock Forecast FAQ
In the current month, KMB has received 3 Buy ratings 12 Hold ratings, and 1 Sell ratings. The KMB average analyst price target in the past 3 months is $142.40.
-
Where Will Kimberly-Clark Stock Be In 1 Year?
According to analysts, the consensus estimate is that Kimberly-Clark share price will rise to $142.40 per share over the next 12 months.
-
What Do Analysts Say About Kimberly-Clark?
Analysts are divided on their view about Kimberly-Clark share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kimberly-Clark is a Sell and believe this share price will drop from its current level to $118.00.
-
What Is Kimberly-Clark's Price Target?
The price target for Kimberly-Clark over the next 1-year time period is forecast to be $142.40 according to 16 Wall Street analysts, 3 of them rate the stock a Buy, 1 rates the stock a Sell, and 12 analysts rate the stock a Hold.
-
Is KMB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Kimberly-Clark is a Hold. 12 of 16 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of KMB?
You can purchase shares of Kimberly-Clark via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kimberly-Clark shares.
-
What Is The Kimberly-Clark Share Price Today?
Kimberly-Clark was last trading at $132.28 per share. This represents the most recent stock quote for Kimberly-Clark. Yesterday, Kimberly-Clark closed at $132.36 per share.
-
How To Buy Kimberly-Clark Stock Online?
In order to purchase Kimberly-Clark stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will KNOT Stock Be In 1 Year?
In the case of KNOT Offshore Partners (KNOP), most headlines…
Why Is Goldman Sachs Stock Up So Much?
Investment banking giant Goldman Sachs (NYSE:GS) has sharply outperformed the…
Stock Ideas
Buy
63
Is NVDA Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 53x
Buy
60
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 42x
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
92
BGL alert for Jul 3
Blue Gold [BGL] is down 20.3% over the past day.
Sell
18
CNC alert for Jul 3
Centene [CNC] is down 1.3% over the past day.
Sell
12
MOH alert for Jul 3
Molina Healthcare [MOH] is up 0.3% over the past day.
